Study identifier:NIS-OGB-IRE-2012/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A multicentre, retrospective chart review study to characterise gefitinib usage and outcomes in routine treatment
lung cancer
-
No
-
All
157
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Oct 2014 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Gefitinib | - |